Vir Biotechnology VIR
NASDAQ VIR
$11.17 -0.12 (-1.06%)
As of: Oct 2, 2026 · 12:53 PM EDT

Vir Biotechnology (VIR) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Vir Biotechnology's Depreciation & Amortization (CF) was $2.8 million in Q2 2026, down 3.9% from $2.92 million a year earlier and down 0.3% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vir Biotechnology's Depreciation & Amortization (CF) was $11.51 million through Jun 30, 2026, down 0.5% year-over-year; for FY2025, it came in at $11.68 million, down 19.8% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $14.56 million in FY2024 (-25.2%), $19.45 million in FY2023 (+186.8%), $6.78 million in FY2022 (+28.0%) and $5.3 million in FY2021 (+20.5%).
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since Q4 2022.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in two of the last eight quarters, with an average decline of 17.7%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2023 (growth of 297.3%); the worst was Q1 2025 (a decline of 36.5%).
  • Per Business Quant data, VIR's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $2.81 million (Q1 2026), $2.9 million (Q4 2025) and $3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn 2.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.80 Mn
Mar 31, 2026 2.81 Mn
Dec 31, 2025 2.90 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 2.92 Mn
Mar 31, 2025 2.87 Mn
Dec 31, 2024 2.89 Mn
Sep 30, 2024 2.90 Mn
Jun 30, 2024 4.26 Mn
Mar 31, 2024 4.52 Mn
Dec 31, 2023 4.48 Mn
Sep 30, 2023 4.50 Mn
Jun 30, 2023 4.60 Mn
Mar 31, 2023 5.64 Mn
Dec 31, 2022 2.35 Mn
Sep 30, 2022 1.60 Mn
Jun 30, 2022 1.50 Mn
Mar 31, 2022 1.42 Mn
Dec 31, 2021 1.40 Mn
Sep 30, 2021 1.40 Mn
API Access

Vir Biotechnology Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VIR&period=max&api_key=YOUR_API_KEY